Medtech
The public listing is expected to value the business at around $46 billion.
Despite the promise of technology-driven innovations, one industry that arguably is slow to adapt to these trends is the medical device industry.
The company will invest $5.5 million to boost its machining and inspection capacity, creating 25 jobs.
A masterplan is currently being prepared with options for the expansion of the company in Galway.
Progenity snagged $125M in funding that will allow the company to accelerate development of its gastrointestinal platform.
The PE firm made the investment just three years ago.
Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort.
The company is pulling these particular devices due to the number of complaints that it received relating to partial stent deployment.
Takeda inked a collaboration deal to develop and commercialize Portal’s needle-free drug delivery device for use with some of Takeda’s biologic medicines.
The new Ethicon factory has attracted a total investment of $180 million.
PRESS RELEASES